The Hospital’s Nelune Comprehensive Cancer (NCCC) provides an integrated, coordinated, patient centred approach to treatment and post-care of cancer patients. Over 5000 cancer patients are treated at the NCCC each year and numbers are increasing by around 100 patients a year. The NCCC’s state of the art radiation therapy service provides specialised care for patients who come from all over NSW and also interstate. The NCCC also houses the biggest hereditary cancer unit in NSW and operates specific cancer service dedicated to young adolescents.
The Prince of Wales Hospital Cancer Survivorship Centre, housed in the beautifully restored Medical Superintendent’s Cottage was generously supported with funding from Dry July to the Prince of Wales Hospital Foundation to provide fit out for waiting room areas and essential virtual care audio visual equipment. The purpose of the Prince of Wales Hospital Cancer Survivorship Centre will be to optimise the health and wellbeing of people living with and beyond cancer by engaging all who are impacted by cancer as empowered partners, and integrating evidence-informed and evidence-generating care to deliver a patient-centred, coordinated, cost-effective, sustainable and innovative cancer survivorship program. The program will focus on prevention, surveillance for recurrence, monitoring and intervention for the physical and psychosocial effects of cancer and cancer treatment.
The centre was developed with funding from the State and Federal governments and the Prince of Wales Hospital Foundation with Dry July funding, and the Sony Foundation and Nelune Foundation. Professor Boon Chua, Director, Cancer and Haematology Services, Prince of Wales Hospital, said the centre will provide a patient-centred, innovative survivorship program – all the more essential now, due to the social and economic impact of the growing number of Australians being affected by cancer. “Cancer survivors are at increased risk for serious long-term morbidity – physical, psychosocial and economic – for quite some time after diagnosis and treatment. Our program will invest in the post-treatment care of those patients – and in training the next generation of clinicians and researchers to support an expanding population of cancer survivors” Professor Chua said.